RR

Rajiv Rajiv Modi

Active Director Director DIN 10276899
DIN 10276899 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 15 active board seats
Total affiliations 15 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 11 Aug 2023
Active appointments 15
Total timeline records 15

Rajiv Rajiv Modi (DIN 10276899) has 15 recorded board appointments in Indian companies, the first from August 2023, of which 15 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2023
Irm Private Limited Director · 2024 – present
Current
Irm Energy Limited Director · 2024 – present
Current
Cadila Pharmaceuticals Limited Director · 2024 – present
Current
Cpl Pharmaceuticals Private Limited Director · 2024 – present
Current
Irm Enterprises Private Limited Director · 2024 – present
Current
Redefine Leisure Private Limited Director · 2024 – present
Current
Inverika Bioresearch Private Limited Director · 2024 – present
Current
Cad Ventures Private Limited Director · 2024 – present
Current
La Vie Biologicals Private Limited Director · 2024 – present
Current
Cpl Infrastructure Private Limited Director · 2024 – present
Current
Cpl Biologicals Private Limited Director · 2024 – present
Current
Magnifik Lifestyle Llp Designated Partner · 2024 – present
Current
Golden Myriad Investment Management Llp Designated Partner · 2023 – present
Current
Renascence Healthcare Private Limited Director · 2023 – present
Current
Mutualist Services Private Limited Director · 2023 – present
Current

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available